Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:Glu-Pro)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST004291 AN007135 Metabolomics analysis of Plasmodium falciparum asexual-stage parasites treated with plasmepsin V peptidomimetics - 16 hour treatment Blood Plasmodium falciparum Malaria Monash University LC-MS
ST004290 AN007133 Metabolomics characterisation of Plasmodium falciparum response to plasmepsin V peptidomimetic inhibitors - 5 hour treatment Blood Plasmodium falciparum Malaria Monash University LC-MS
ST004227 AN007035 Comparative untargeted metabolomics analysis the wheat grains in cultivars zhengmai 7698 and zhoumai 22 Seeds Wheat Henan Academy of Agricultural Sciences LC-MS
ST004153 AN006895 Multi-omics Study of Small Intestine Adaptation After Total Colectomy in a Rat model Feces Rat Shanghai Jiao Tong University LC-MS
ST004144 AN006869 Metabolic rewiring in isogenic SW48 colorectal cancer cells with different oncogenic KRAS G12 point mutations Cultured cells Human Cancer Brunel University of London LC-MS
ST003911 AN006421 Molecular fingerprint inference reveals bioactive lipids and microbial metabolites in colitis. Study 4 Bacterial cells Eggerthella lenta Inflammatory bowel disease Broad Institute of MIT and Harvard LC-MS
ST003911 AN006421 Molecular fingerprint inference reveals bioactive lipids and microbial metabolites in colitis. Study 4 Bacterial cells Fusobacterium nucleatum Inflammatory bowel disease Broad Institute of MIT and Harvard LC-MS
ST003910 AN006418 Molecular fingerprint inference reveals bioactive lipids and microbial metabolites in colitis. Study 3. Bacterial cells Bifidobacteria Inflammatory bowel disease Broad Institute of MIT and Harvard LC-MS
ST003910 AN006418 Molecular fingerprint inference reveals bioactive lipids and microbial metabolites in colitis. Study 3. Bacterial cells Clostridium Inflammatory bowel disease Broad Institute of MIT and Harvard LC-MS
ST003910 AN006418 Molecular fingerprint inference reveals bioactive lipids and microbial metabolites in colitis. Study 3. Bacterial cells Escherichia coli Inflammatory bowel disease Broad Institute of MIT and Harvard LC-MS
ST003910 AN006418 Molecular fingerprint inference reveals bioactive lipids and microbial metabolites in colitis. Study 3. Bacterial cells Streptococcus Inflammatory bowel disease Broad Institute of MIT and Harvard LC-MS
ST003880 AN006373 Untargeted metabolome analysis of control and disease intervertebral disc tissue Tissue Human Bone disease Ganga Orthopaedic Research and Education Foundation LC-MS
ST003817 AN006275 Irisin promotes bone tissue repair and intestinal protection in osteoporotic mice Feces Mouse Osteoporosis Huizhou Central People's Hospital LC-MS
ST003768 AN006185 The Chromosome-Scale Assembly and Multi-Omics Analysis Reveal Adaptive Evolution and Nitrogen Utilization Mechanisms in Edible Grass Leaf Grass Hunan Agricultural University LC-MS
ST003768 AN006185 The Chromosome-Scale Assembly and Multi-Omics Analysis Reveal Adaptive Evolution and Nitrogen Utilization Mechanisms in Edible Grass Roots Grass Hunan Agricultural University LC-MS
ST003712 AN006093 ndufs2-/- mitochondrial Leigh syndrome zebrafish model has shortened lifespan, morphologic anomalies, and altered one-carbon metabolism Larvae Zebrafish Mitochondrial disease Children's Hospital of Philadelphia LC-MS
ST003587 AN005891 Comparison of Machine Learning Models for Metabolomic-Based Clinical Prediction of Preterm Birth Blood Human University of Calgary LC-MS
ST003521 AN005782 Metabolic Profiling Unveils Enhanced Antibacterial Synergy of Polymyxin B and Teixobactin against Multi-Drug Resistant Acinetobacter baumannii Bacterial cells Acinetobacter baumannii Bacterial infection Monash University LC-MS
ST003521 AN005783 Metabolic Profiling Unveils Enhanced Antibacterial Synergy of Polymyxin B and Teixobactin against Multi-Drug Resistant Acinetobacter baumannii Bacterial cells Acinetobacter baumannii Bacterial infection Monash University LC-MS
ST003499 AN005743 Metabolic analysis of ADSL deficiency patients' EBV-LCLs. Blood Human Mitochondrial disease Catholic University of the Sacred Heart LC-MS
ST003499 AN005744 Metabolic analysis of ADSL deficiency patients' EBV-LCLs. Blood Human Mitochondrial disease Catholic University of the Sacred Heart LC-MS
ST003356 AN005497 Noninvasive multiomic measurement of cell type repertoires in human urine Urine Human Urinary tract infection CZ Biohub LC-MS
ST003347 AN005482 ADSL deficiency drives mitochondrial dysfunction and ERK2 dysregulation in a linear genotype to phenotype correlation Skin Human Neuropathy Catholic University of the Sacred Heart LC-MS
ST003160 AN005184 New class of heterospirocyclic compounds present strong and rapid activity against artemisinin- and multidrug-resistant P. falciparum parasites Plasmodium cells Plasmodium falciparum Malaria Monash University LC-MS
ST003024 AN004958 Identifying and mathematically modeling the time-course of extracellular metabolic markers associated with resistance to ceftolozane/tazobactam in Pseudomonas aeruginosa - Part 1 Bacterial cells Pseudomonas aeruginosa Monash Institute of Pharmaceutical Sciences LC-MS
ST002832 AN004626 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Bacteroides fragilis Stanford University LC-MS
ST002832 AN004626 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Bacteroides thetaiotaomicron Stanford University LC-MS
ST002832 AN004626 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Bacteroides uniformis Stanford University LC-MS
ST002832 AN004626 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Blautia producta Stanford University LC-MS
ST002832 AN004626 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Clostridium clostridioforme Stanford University LC-MS
ST002832 AN004626 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Clostridium hathewayi Stanford University LC-MS
ST002832 AN004626 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Clostridium hylemonae Stanford University LC-MS
ST002832 AN004626 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Clostridium scindens Stanford University LC-MS
ST002832 AN004626 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Clostridium symbiosum Stanford University LC-MS
ST002832 AN004626 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Enterococcus faecalis Stanford University LC-MS
ST002832 AN004626 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Enterococcus faecium Stanford University LC-MS
ST002832 AN004626 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Enterococcus hirae Stanford University LC-MS
ST002832 AN004626 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Escherichia fergusonii Stanford University LC-MS
ST002832 AN004626 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Flavonifractor plautii Stanford University LC-MS
ST002832 AN004626 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Parabacteroides distasonis Stanford University LC-MS
ST002787 AN004534 Metabolomic analysis of gut metabolites in colorectal cancer patients: correlation with disease development and outcome Feces Human Cancer Wuhan University of Science and Technology LC-MS
ST002761 AN004489 Metabolic responses of normal rat kidneys to a high salt intake (Urine) Urine Rat Medical College of Wisconsin LC-MS
ST002747 AN004455 Evolutionary genomics identifies host-directed therapeutics to treat intracellular bacterial infections Cultured cells Human CZ Biohub LC-MS
ST002747 AN004455 Evolutionary genomics identifies host-directed therapeutics to treat intracellular bacterial infections Cultured cells Rickettsia parkeri CZ Biohub LC-MS
ST002516 AN004143 Time course 2: Growth of Eggerthella lenta in defined media with some samples receiving 13C2 stable isotope labeled acetate Bacterial media Eggerthella lenta University of California, San Francisco LC-MS
ST002509 AN004131 Time course 1: Growth of Eggerthella lenta in defined media Bacterial media Eggerthella lenta University of California, San Francisco LC-MS
ST002505 AN004126 A Mammalian Conserved Circular RNA CircLARP2 Regulates Hepatocellular Carcinoma Metastasis and Lipid Metabolism (Part 1) Cultured cells Human Cancer University of Science and Technology of China LC-MS
ST002477 AN004046 Neutrophil metabolomics in COVID-19 Neutrophils Human COVID-19 UT Southwestern Medical Center LC-MS
ST002407 AN003924 Spatial, temporal, and inter-subject variation of the metabolome along the human upper intestinal tract Intestine Human University of California, Davis LC-MS
ST002405 AN003919 Stool global metabolite levels in peanut allergy (Part 2) Feces Human Peanut allergy Icahn School of Medicine at Mount Sinai LC-MS
ST002247 AN003670 Microbiota and Health Study (Dhaka, Bangladesh) Feces Human Broad Institute of MIT and Harvard LC-MS
ST002231 AN003640 Metabolomics Analysis of HOG-EV and HOG-R132H Cells with and without BAY 2402234 Treatment Cultured cells Human Cancer UT Southwestern Medical Center LC-MS
ST002107 AN003447 Genetic and chemical validation of Plasmodium falciparum aminopeptidase PfA-M17 as a drug target in the hemoglobin digestion pathway (Part 2) Blood Plasmodium falciparum Malaria Monash University LC-MS
ST002106 AN003444 Genetic and chemical validation of Plasmodium falciparum aminopeptidase PfA-M17 as a drug target in the hemoglobin digestion pathway (Part 1) Blood Plasmodium falciparum Malaria Monash University LC-MS
ST002028 AN003298 Metabolomics Analysis of Blood Plasma and Stool from Six Week Flaxseed Dietary Intervention in Postmenopausal Women (Stool/HILIC) Feces Human University of California, Davis LC-MS
ST002027 AN003297 Metabolomics Analysis of Blood Plasma and Stool from Six Week Flaxseed Dietary Intervention in Postmenopausal Women (Serum/HILIC) Blood Human University of California, Davis LC-MS
ST001794 AN002911 Metabolomics Analysis of Time-Series Gastrointestinal Lumen Samples Jejunum Human University of California, Davis LC-MS
ST001658 AN002706 Control of Topoisomerase II Activity and Chemotherapeutic Inhibition by TCA Cycle Metabolites Yeast cells Saccharomyces cerevisiae Cancer Johns Hopkins University LC-MS
ST001658 AN002708 Control of Topoisomerase II Activity and Chemotherapeutic Inhibition by TCA Cycle Metabolites Yeast cells Saccharomyces cerevisiae Cancer Johns Hopkins University LC-MS
ST001658 AN002709 Control of Topoisomerase II Activity and Chemotherapeutic Inhibition by TCA Cycle Metabolites Yeast cells Saccharomyces cerevisiae Cancer Johns Hopkins University LC-MS
ST001324 AN002202 Metabolomics Adaptation of Juvenile Pacific Abalone Haliotis discus hannai to Heat Stress Hepatopancreas Pacific Abalone Institute of Oceanology, Chinese Academy of Sciences LC-MS
ST001205 AN002006 Peroxide antimalarial treatment of K13-mutant and -wildtype P. falciparum parasites Cultured cells Human Malaria Monash University LC-MS
ST001205 AN002006 Peroxide antimalarial treatment of K13-mutant and -wildtype P. falciparum parasites Cultured cells Plasmodium falciparum Malaria Monash University LC-MS
ST001204 AN002004 Peroxide antimalarial extended treatment timecourse on trophozoite-stage P. falciparum parasites Cultured cells Human Malaria Monash University LC-MS
ST001204 AN002004 Peroxide antimalarial extended treatment timecourse on trophozoite-stage P. falciparum parasites Cultured cells Plasmodium falciparum Malaria Monash University LC-MS
ST001202 AN002000 Peroxide antimalarial treatment timecourse on ring-stage P. falciparum parasites Cultured cells Human Malaria Monash University LC-MS
ST001202 AN002000 Peroxide antimalarial treatment timecourse on ring-stage P. falciparum parasites Cultured cells Plasmodium falciparum Malaria Monash University LC-MS
ST001201 AN001998 Peroxide antimalarial treatment timecourse on trophozoite-stage P. falciparum parasites Cultured cells Human Malaria Monash University LC-MS
ST001201 AN001998 Peroxide antimalarial treatment timecourse on trophozoite-stage P. falciparum parasites Cultured cells Plasmodium falciparum Malaria Monash University LC-MS
ST001175 AN001950 Multi-omics analysis demonstrates unique mode of action of a potent new antimalarial compound, JPC-3210, against Plasmodium falciparum Plasmodium cells Plasmodium falciparum Malaria Monash University LC-MS
ST000539 AN000818 Metabolomics-based elucidation of active metabolic pathways in erythrocytes and HSC-derived reticulocytes (part II) Cells Human Monash University LC-MS
ST000403 AN000642 Metabolomics-based elucidation of active metabolic pathways in erythrocytes and HSC-derived reticulocytes Cells Human Monash Institute of Pharmaceutical Sciences LC-MS
  logo